National Hospital Org. Hokkaido Cancer Center

Sapporo 003-0804

0 studies enrolling now · 1 studies all time

What they study most

B-Cell Malignancies

Studies at this site

• Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465) — Running, not enrolling